Establishment of the Heart and Brain Team for Patent Foramen Ovale Closure in Stroke Patients: An Expert Opinion
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
The online 2021 Asian-Pacific Heart and Brain Summit was organized to present and discuss experiences within leading Asian-Pacific centers with regard to institutional heart and brain teams managing the diagnosis, treatment, and follow-up of cryptogenic stroke (CS) patients with patent foramen ovale (PFO). This manuscript presents a narrative review of presentations and discussions during the summit meeting. Percutaneous PFO closure is an established therapy for CS patients in whom PFO is considered to be causal. Guidelines and consensus statements emphasize the importance of multidisciplinary clinical decision-making regarding PFO closure with the involvement of several clinical specialties, including neurology, cardiology, and hematology. It is also recommended that the patient be closely involved in this process. The heart and brain team is a collaborative platform that facilitates such a multidisciplinary decision-making process and patient involvement. It also creates opportunities for education and evaluation of the healthcare provided to patients with CS. This review provides insights into the implementation, composition, organization, and operation of a heart and brain team. Methods and metrics are suggested to evaluate the team’s role. We suggest that an efficient heart and brain team can implement guideline-recommended multidisciplinary clinical decision-making with regard to PFO closure in CS patients and play an important role in the management of these patients.
Abstract
The online 2021 Asian-Pacific Heart and Brain Summit was organized to present and discuss experiences within leading Asian-Pacific centers with regard to institutional heart and brain teams managing the diagnosis, treatment, and follow-up of cryptogenic stroke (CS) patients with patent foramen ovale (PFO). This manuscript presents a narrative review of presentations and discussions during the summit meeting. Percutaneous PFO closure is an established therapy for CS patients in whom PFO is considered to be causal. Guidelines and consensus statements emphasize the importance of multidisciplinary clinical decision-making regarding PFO closure with the involvement of several clinical specialties, including neurology, cardiology, and hematology. It is also recommended that the patient be closely involved in this process. The heart and brain team is a collaborative platform that facilitates such a multidisciplinary decision-making process and patient involvement. It also creates opportunities for education and evaluation of the healthcare provided to patients with CS. This review provides insights into the implementation, composition, organization, and operation of a heart and brain team. Methods and metrics are suggested to evaluate the team’s role. We suggest that an efficient heart and brain team can implement guideline-recommended multidisciplinary clinical decision-making with regard to PFO closure in CS patients and play an important role in the management of these patients.
참고문헌 (30)
- Søndergaard L, "Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke", N Engl J Med, 377, pp.1033~1042 (2017)
- Saver JL, "Long-term outcomes of patent foramen ovale closure or medical therapy after stroke", N Engl J Med, 377, pp.1022~1032 (2017)
- Mas JL, "Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke", N Engl J Med, 377, pp.1011~1021 (2017)
- Lee PH, "Cryptogenic stroke and high-risk patent foramen ovale : the DEFENSE-PFO trial", J Am Coll Cardiol, 71, pp.2335~2342 (2018)
- Furlan AJ, "Closure or medical therapy for cryptogenic stroke with patent foramen ovale", N Engl J Med, 366, pp.991~999 (2012)
- Meier B, "Percutaneous closure of patent foramen ovale in cryptogenic embolism", N Engl J Med, 368, pp.1083~1091 (2013)
- Ntaios G, "Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack : updated systematic review and meta-analysis", Stroke, 49, pp.412~418 (2018)
- Kent DM, "Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke", JAMA, 326, pp.2277~2286 (2021)
- Pristipino C, "European position paper on the management of patients with patent foramen ovale : general approach and left circulation thromboembolism", EuroIntervention, 14, pp.1389~1402 (2019)
- Horlick E, "SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke: the American Academy of Neurology affirms the value of this statement as an educational tool for neurologists", Catheter Cardiovasc Interv, 93, pp.859~874 (2019)
- Kleindorfer DO, "2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack : a guideline from the American Heart Association", American Stroke Association, 2021, pp.52, e364~e467
- Messé SR, "Practice advisory update summary: patent foramen ovale and secondary stroke prevention: report of the guideline subcommittee of the American Academy of Neurology", Neurology, 94, pp.876~885 (2020)
- "Amplatzer PFO occlude: instructions for use" (2022)[URL]
- "Gore Cardioform: instructions for use" (2022)[URL]
- Buck BH, "Effect of implantable vs prolonged external electrocardiographic monitoring on atrial fibrillation detection in patients with ischemic stroke : the PER DIEM randomized clinical trial", JAMA, 325, pp.2160~2168 (2021)
- Thijs VN, "Predictors for atrial fibrillation detection after cryptogenic stroke : results from CRYSTAL AF", Neurology, 86, pp.261~269 (2016)
- Xu J, "Predictors of atrial fibrillation detection and features of recurrent strokes in patients after cryptogenic stroke", J Stroke Cerebrovasc Dis, 29, pp.104934~ (2020)
- Sudacevschi V, "Predictors of occult atrial fibrillation in one hundred seventy-one patients with cryptogenic transient ischemic attack and minor stroke", J Stroke Cerebrovasc Dis, 25, pp.2673~2677 (2016)
- Elgendy AY, "Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke", JAMA Neurol, 77, pp.878~886 (2020)
- Kent DM, "An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke", Neurology, 81, pp.619~625 (2013)
- Peter D. Schellinger, "Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: Review and Critical Appraisal", 대한뇌졸중영문학회지, 20(3), pp.281~291 (2018), 대한뇌졸중학회
- Ignacio Cruz-González, "Left Atrial Appendage Occlusion: An Alternative to Triple Therapy in Stroke Patients Undergoing Carotid Angioplasty", 대한뇌졸중영문학회지, 22(2), pp.268~270 (2020), 대한뇌졸중학회[DOI]
- Collado FM, "The heart-brain team approach in patent foramen ovale closure", Front Neurol, 11, pp.561938~ (2020)
- Kasner SE, "Uncertainties and controversies in the management of ischemic stroke and transient ischemic attack patients with patent foramen ovale", Stroke, 52, pp.e806~e819 (2021)
- Morais LA, "RoPE score as a predictor of recurrent ischemic events after percutaneous patent foramen ovale closure", Int Heart J, 59, pp.1327~1332 (2018)
- Mazzucco S, "Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis", Lancet Neurol, 17, pp.609~617 (2018)
- Hanim Kwon, "Patent Foramen Ovale Closure in Old Stroke Patients: A Subgroup Analysis of the DEFENSE-PFO Trial", 대한뇌졸중영문학회지, 23(2), pp.289~292 (2021), 대한뇌졸중학회[DOI]
- Jong S. Kim, "Patent Foramen Ovale Closure: Opportunity Closed in Old Patients?", 대한뇌졸중영문학회지, 23(2), pp.147~148 (2021), 대한뇌졸중학회[DOI]
- Minyoul Baik, "Patent Foramen Ovale and Risk of Recurrence in Stroke of Determined Etiology", Annals of Neurology, 92(4), pp.596~606 (2022), Wiley[DOI]
- Tobis JM, "Percutaneous closure of patent foramen ovale in patients with migraine : the premium trial", J Am Coll Cardiol, 70, pp.2766~2774 (2017)